Raymond James loses $762,000 penny stock arbitration claim

More than 20 claimants initially sought $8.8 million in damages and costs after a Morgan Keegan adviser allegedly misappropriated their funds

Mar 1, 2017 @ 2:38 pm

By Bruce Kelly

Raymond James & Associates Inc. was tagged last week to pay $762,000 in an arbitration case stemming from penny stocks a legacy Morgan Keegan financial adviser bought for clients from 2007 to 2010.

Raymond James & Associates is the employee broker-dealer arm of Raymond James Financial Inc., the holding company that acquired Morgan Keegan & Co. Inc. in 2012 for $1.18 billion from Regions Financial Corp.

More than 20 claimants initially filed the arbitration claim against the firm in 2014 and sought $8.8 million in damages and costs, alleging that their Morgan Keegan adviser, who is not named in the complaint and is no longer in the securities industry, "misappropriated their retirement assets in unsuitable investments, including variable annuities and penny stocks, at significant costs" to the investors, according to the award, which was finalized on Friday.

"Claimants further alleged that Logan Burch Phillips, as branch manager at Morgan Keegan & Co., approved or directed their financial adviser's misdeeds and failed to protect the assets" of the investors, according to the award, which was issued by the Finra office of dispute resolution.

Eight of the investors settled with Raymond James & Associates in the matter, according to their attorney, Judson Lee. Twelve received the award, and two claims were denied.

"You couldn't have this penny stock scam without management knowing about it or turning a blind eye," said Mr. Lee. "All trades had to be approved and were unsuitable for the clients," who were predominately retirees, he added.

"Our case was built on a failure to supervise," Mr. Lee said.

The claimants received $327,000 in compensatory damages, $200,000 in punitive damages, attorneys' fees of $211,000 and costs of $24,000. Punitive damages are unusual in Finra arbitration awards.

"While we disagree that an award of any amount was justified, the arbitrators awarded less than 10% of the $8.8 million sought at hearing and denied the claims of two of the claimants in their entirety," wrote Raymond James spokeswoman Anthea Penrose.

When Raymond James bought Morgan Keegan, the firm was reeling from a mutual fund scandal after investors lost money in proprietary mutual funds that held mortgage-backed securities when the housing market collapsed in 2007. Regions Financial coughed up hundreds of millions of dollars to settle regulatory charges in the matter, and investors sued the firm in Finra arbitration.

"Morgan Keegan is kind of the gift that keeps on giving to claimants lawyers and is an ongoing nightmare for Raymond James," said Andrew Stoltmann, a plaintiff's attorney. "The reputational hits continue to come. These sorts of debacles have to drive Raymond James crazy."

0
Comments

What do you think?

View comments

Recommended for you

Sponsored financial news

Featured video

Events

How 401(k) advisers can use 'centers of influence' to grow their business

Leveraging relationships with accounting, benefits, and property and casualty insurance firms can help deliver new business leads for retirement plan advisers.

Latest news & opinion

Things are looking up: IBDs soared in 2017

With revenue up, interest rates rising and regulation easing, IBDs are soaring.

SEC advice rule may give RIAs leg up over broker-dealers

Experts say advisers will be able to point to their role as fiduciaries as a differentiator in the advice market.

Brokers accept proposed SEC rule on who can call themselves an adviser

Some say the rule will clear up investor confusion, but others say the SEC didn't go far enough.

Cadaret Grant acquired by private-equity-backed Atria

75-year-old owner Arthur Grant positions the IBD for the 'next 33 years.'

SEC advice rule seeks to tighten reins on brokers

The proposed rule puts new restrictions on brokers, but it is still unclear how strongly the SEC is clamping down.

X

Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting investmentnews.com? It'll help us continue to serve you.

Yes, show me how to whitelist investmentnews.com

Ad blocker detected. Please whitelist us or give premium a try.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print